このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Medacta Group SA 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | CHF 123.20 |
| 52週高値 | CHF 135.00 |
| 52週安値 | CHF 98.10 |
| ベータ | 1.14 |
| 11ヶ月の変化 | -5.52% |
| 3ヶ月変化 | 0.82% |
| 1年変化 | 6.39% |
| 33年間の変化 | -13.24% |
| 5年間の変化 | 55.36% |
| IPOからの変化 | 28.20% |
最新ニュース
Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate
Sep 06
What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?
Aug 21Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
Aug 06Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable
Jun 20We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 01Recent updates
Medacta Group SA (VTX:MOVE) Shares Could Be 32% Above Their Intrinsic Value Estimate
Sep 06What Does Medacta Group SA's (VTX:MOVE) Share Price Indicate?
Aug 21Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
Aug 06Medacta Group SA's (VTX:MOVE) P/E Still Appears To Be Reasonable
Jun 20We Discuss Why Medacta Group SA's (VTX:MOVE) CEO Will Find It Hard To Get A Pay Rise From Shareholders This Year
May 01Medacta Group (VTX:MOVE) Has A Pretty Healthy Balance Sheet
Apr 17Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Mar 29Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Feb 22Medacta Group (VTX:MOVE) Will Be Hoping To Turn Its Returns On Capital Around
Feb 07Getting In Cheap On Medacta Group SA (VTX:MOVE) Might Be Difficult
Dec 18Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Dec 04Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Nov 15Returns On Capital Signal Tricky Times Ahead For Medacta Group (VTX:MOVE)
Oct 30If EPS Growth Is Important To You, Medacta Group (VTX:MOVE) Presents An Opportunity
Oct 17Is Medacta Group (VTX:MOVE) Using Too Much Debt?
Sep 29Calculating The Intrinsic Value Of Medacta Group SA (VTX:MOVE)
Aug 11Is Now The Time To Look At Buying Medacta Group SA (VTX:MOVE)?
Jul 27Be Wary Of Medacta Group (VTX:MOVE) And Its Returns On Capital
Jul 03At CHF117, Is It Time To Put Medacta Group SA (VTX:MOVE) On Your Watch List?
Apr 28Is Medacta Group (VTX:MOVE) A Risky Investment?
Apr 08Is Now An Opportune Moment To Examine Medacta Group SA (VTX:MOVE)?
Dec 25Capital Allocation Trends At Medacta Group (VTX:MOVE) Aren't Ideal
Dec 09Does Medacta Group (VTX:MOVE) Have A Healthy Balance Sheet?
Nov 09Why Medacta Group SA (VTX:MOVE) Could Be Worth Watching
Sep 16The Returns On Capital At Medacta Group (VTX:MOVE) Don't Inspire Confidence
Aug 20Here's Why Medacta Group (VTX:MOVE) Has Caught The Eye Of Investors
Jul 02Should You Think About Buying Medacta Group SA (VTX:MOVE) Now?
May 28Medacta Group (VTX:MOVE) Is Reinvesting At Lower Rates Of Return
May 12These 4 Measures Indicate That Medacta Group (VTX:MOVE) Is Using Debt Reasonably Well
Mar 31Does Medacta Group (VTX:MOVE) Deserve A Spot On Your Watchlist?
Mar 17Capital Investments At Medacta Group (VTX:MOVE) Point To A Promising Future
Feb 07Should You Investigate Medacta Group SA (VTX:MOVE) At CHF133?
Dec 10Medacta Group (VTX:MOVE) Knows How To Allocate Capital
Nov 05Here's Why Medacta Group (VTX:MOVE) Can Manage Its Debt Responsibly
Sep 30Is It Too Late To Consider Buying Medacta Group SA (VTX:MOVE)?
Aug 26Medacta Group (VTX:MOVE) May Have Issues Allocating Its Capital
Jul 20Should You Investigate Medacta Group SA (VTX:MOVE) At CHF119?
May 19We Think Medacta Group (VTX:MOVE) Can Stay On Top Of Its Debt
Apr 05What You Need To Know About Medacta Group SA's (VTX:MOVE) Investor Composition
Mar 02Is Medacta Group SA's (VTX:MOVE) 7.6% ROE Better Than Average?
Feb 02The Medacta Group (VTX:MOVE) Share Price Has Gained 24% And Shareholders Are Hoping For More
Jan 12
Returns On Capital At Medacta Group (VTX:MOVE) Paint An Interesting Picture
Dec 21Should You Use Medacta Group's (VTX:MOVE) Statutory Earnings To Analyse It?
Dec 03株主還元
| MOVE | CH Medical Equipment | CH 市場 | |
|---|---|---|---|
| 7D | 5.1% | 4.6% | 2.7% |
| 1Y | 6.4% | 21.6% | 9.6% |
業界別リターン: MOVE過去 1 年間で9.7 % の収益を上げたSwiss Medical Equipment業界を下回りました。
リターン対市場: MOVEは、過去 1 年間で9.4 % のリターンを上げたSwiss市場を下回りました。
価格変動
| MOVE volatility | |
|---|---|
| MOVE Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 6.7% |
| 10% least volatile stocks in CH Market | 1.6% |
安定した株価: MOVE過去 3 か月間に大きな価格変動はありませんでした。
時間の経過による変動: MOVEの 週次ボラティリティ ( 3% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1958 | 1,696 | Francesco Siccardi | www.medacta.com |
Medacta Group SAは、整形外科および神経外科用医療機器の開発、製造、販売を欧州、北米、アジア太平洋地域、および国際的に行っている。股関節、膝関節、肩関節、人工関節置換術、スポーツ医学、脊椎の手術に使用するパーソナライズされた3Dプランニングツールを提供している。メダクタ・グループSAは1958年に設立され、スイスのカステル・サン・ピエトロに本社を置いている。
Medacta Group SA 基礎のまとめ
| MOVE 基礎統計学 | |
|---|---|
| 時価総額 | CHF 2.46b |
| 収益（TTM） | CHF 52.76m |
| 売上高(TTM) | CHF 510.91m |
46.5x
PER（株価収益率4.8x
P/SレシオMOVE は割高か？
公正価値と評価分析を参照収益と収入
| MOVE 損益計算書（TTM） | |
|---|---|
| 収益 | €544.29m |
| 売上原価 | €174.57m |
| 売上総利益 | €369.72m |
| その他の費用 | €313.51m |
| 収益 | €56.21m |
直近の収益報告
Jun 30, 2024
次回決算日
該当なし
| 一株当たり利益（EPS） | 2.82 |
| グロス・マージン | 67.93% |
| 純利益率 | 10.33% |
| 有利子負債／自己資本比率 | 54.1% |
MOVE の長期的なパフォーマンスは？
過去の実績と比較を見る